Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001104659-23-122019
Filing Date
2023-11-29
Accepted
2023-11-29 16:00:17
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm2331756d1_sc13da.htm SC 13D/A 57166
  Complete submission text file 0001104659-23-122019.txt   58389
Mailing Address CHEMIN DES MINES 9 GENEVA V8 CH-1202
Business Address CHEMIN DES MINES 9 GENEVA V8 CH-1202 01141228841555
Addex Therapeutics Ltd. (Subject) CIK: 0001574232 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-91805 | Film No.: 231452091
SIC: 2834 Pharmaceutical Preparations

Mailing Address CHEMIN DES MINES 9 CH-1202 GENEVA V8 CH-1202
Business Address
Dyer Timothy Mark (Filed by) CIK: 0001830908 (see all company filings)

Type: SC 13D/A